Baichuan founder and CEO Wang Xiaochuan said the company plans to pursue an IPO by 2027. He noted that while many
AI firms benefit from policy and technology tailwinds, their valuations have outpaced commercialization. Wang added that Baichuan’s long-term strategy, particularly in healthcare, remains centered on sustainable growth toward a public listing.